Edward T. Creagan

Mayo Clinic — United States

Medicine · Health Sciences

42h-index7.2kcitations178works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Research Studies(26), Lung Cancer Treatments and Mutations(24), CAR-T cell therapy research(23), Cutaneous Melanoma Detection and Management(22), Immunotherapy and Immune Responses(21)

Publications178 total

Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly
Cancer Cell·2018· 202 citedOpen Access
Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG-N0377, Alliance)
The Oncologist·2018· 14 citedOpen Access
Initial Clinical Validation of The Oxygen Plan Stress Number
2018
The design of visitation facilities to engage patients with their own cats and dogs
Complementary Therapies in Clinical Practice·2017· 2 cited
Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma
Melanoma Research·2017· 27 cited
Animal-assisted therapy at Mayo Clinic: The time is now
Complementary Therapies in Clinical Practice·2015· 106 cited
Phase II Study of Temozolomide (TMZ) and Everolimus (RAD001) Therapy for Metastatic Melanoma
American Journal of Clinical Oncology·2013· 42 citedOpen Access
Is age ≥70years an important predictor of adverse events among patients enrolled in metastatic melanoma trials? Findings from pooled analyses of therapeutic trials
Journal of Geriatric Oncology·2012· 3 citedOpen Access
Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine
Melanoma Research·2011· 18 cited
Mayo Clinic office visit. Palliative care. An interview with Edward Creagan, M.D., F.A.A.H.P.M.
PubMed·2011
N0675: NCCTG phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma (MM).
Journal of Clinical Oncology·2010· 3 cited
A Novel Advance Directives Course Provides a Transformative Learning Experience for Medical Students
Teaching and Learning in Medicine·2010· 7 cited
Cancer Patients and Their Companion Animals: Results from a 309-Patient Survey on Pet-Related Concerns and Anxieties During Chemotherapy
Journal of Cancer Education·2010· 28 cited
Erratum
Oncology·2009· 1 citedOpen Access
Possible therapeutic reversal of immune suppression in patients with metastatic melanoma by timed delivery of temozolomide chemotherapy: A pilot study
Journal of Clinical Oncology·2009· 5 cited
Survival trends in palliative care patients with cancer: A Mayo Clinic 5-year review
Journal of Clinical Oncology·2009· 1 cited
A Dose-Escalation Study of Aerosolized Sargramostim in the Treatment of Metastatic Melanoma
American Journal of Clinical Oncology·2008· 28 citedOpen Access
Start Strong, Finish Strong: Prescriptions for a Lifetime of Great Health
Mayo Clinic Proceedings·2008· 1 cited
Do patients with schizophrenia receive state‐of‐the‐art lung cancer therapy? A brief report
Psycho-Oncology·2007· 23 citedOpen Access
N0377: Results of NCCTG phase II trial of the mTOR inhibitor RAD-001 in metastatic melanoma
Journal of Clinical Oncology·2007· 12 cited
page 1 of 9Next →

Frequent Co-authors

David L. Ahmann(15), Stephen Frytak(13), James N. Ingle(9), Harry J. Long(8), Svetomir N. Markovic(7), John H. Edmonson(6), Richard G. Hahn(6), Judith R. OʼFallon(5), Lisa A. Kottschade(5), Joseph Rubin(5), Loretta M. Itri(5), John E. Woods(5), Charles G. Moertel(4), Lori A. Erickson(4), Ravi D. Rao(4), Robert R. McWilliams(4), Mark R. Pittelkow(4), Barbara A. Pockaj(4), William J. Maples(4), Harry F. Bisel(4)